The relationship between procollagen-III-peptide and the severity of esophageal varices in children with biliary atresia after Kasai operation

Pediatric Surgery International

Volumn 18, Issue 1, 2002, Pages 32-35

  Sathienkijakarnchai, Prasert ^a   Chongsrisawat, Voranush ^a   Charoensapaya, Jongrak ^a   Tanprayoon, Taveesin ^a   Chandrakamol, Bidhya ^a   Suwangool, Pongspeera ^a   Poovorawan, Yong ^a  

^a KING CHULALONGKORN MEMORIAL HOSPITAL   (Thailand)

Author keywords

Biliary atresia; Esophageal varices; Kasai operation; Procollagen III peptide

Indexed keywords

PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BILE DUCT ATRESIA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGUS VARICES; FEMALE; HUMAN; MALE; PORTAL HYPERTENSION; PORTOENTEROSTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SEX DIFFERENCE;

ADOLESCENT; ANALYSIS OF VARIANCE; BILIARY ATRESIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HUMANS; INFANT; LIVER FUNCTION TESTS; MALE; PEPTIDE FRAGMENTS; PROCOLLAGEN; RADIOIMMUNOASSAY; SEVERITY OF ILLNESS INDEX;

EID: 0036461048     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003830200007     Document Type: Article

References (32)

1. Dussaix E, Hadchvuel M, Tardieu M, Alagille D (1984) Biliary atresia and reovirus type 3 infection. N Engl J Med 310: 658
2. Glaser JH, Balistreri WF, Morecki R (1984) Role of reovirus type 3 in persistent infantile cholestasis. J Pediatr 105: 912-915
3. Riepenhoff-Talty M, Gouvea V, Evans MJ, et al (1996) Detection of group C rotavirus in infants with extrahepatic biliary atresia. J Infect Dis 174: 8-15
4. Desmet VJ (1992) Congenital disease of intrahepatic bile ducts: variations on the theme "ductal plate malformation." Hepatology 16: 1069-1083
5. Ho CW, Shioda K, Shirasaki K, Takahashi S, Tokimatsu S, Maeda K (1993) The pathogenesis of biliary atresia: a morphological study of the hepatobiliary system and the hepatic artery. J Pediatr Gastroenterol Nutr 16: 53-60
6. Karrer F, Price M, Bensark D, Sokol R, Narkewiez M, Smith D, Lilly J (1996) Long-term results with the Kasai operation for biliary atresia. Arch Surg 131: 493-496
7. Brenner DB, Alcorn JM (1982) Pathogenesis of HF. In: Karplomtz N (ed) Liver and biliary diseases. Williams and Wilkins, Baltimore, pp 118-130
8. Strobel D, Hahn E (1997) Pathogenesis of liver fibrogenesis. Digestion 58: 37-38
9. Trivedi P, Dhawan A, Risteli L, Mirza M, Cheeseman P, Mowat AP (1995) Prognostic value of serum hyaluronic acid and type I and type III procollagen propeptides in extrahepatic biliary atresia. Pediatr Res 38: 568-573
10. Stern R, Tseng S (1981) The fibrosis of chronic alcoholic liver disease. In: Berk P, Chambers T (eds) Frontiers in liver disease. Thieme-Stratton, New York, pp 142-155
11. Kobayashi H, Miyano T, Horichoshi K, Tokita A (1998) Prognostic value of serum procollagen-III-peptide and type IV collagen in patients with biliary atresia. J Pediatr Surg 33: 112-114
12. Sosaki F, Hata Y, Hamada H, Takahashi H, Uchino J (1992) Laminin and procollagen-III-peptide as a serum marker for HF in congenital biliary atresia. J Pediatr Surg 27: 700-703
13. Kobayashi H, Miyano T, Horikushi K, Orihata K, Watanabe S, Futagawa S (1989) Clinical significance of plasma endothelin levels in patients with biliary atresia. Pediatr Surg Int 13: 491-493
14. Hirayama C, Suzuki H, Takada A, Fujisawa K, Tanikawa K, Igarashi S (1996) Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide. J Gastroenterol 31: 242-248
15. Valayer J (1996) Conventional treatment of biliary atresia: long-term results. J Pediatr Surg 31: 1546-1551
16. Bates MD, Bucuvalas JC, Alonso MH, Ryckman FC (1998) Biliary atresia: pathogenesis and treatment. Semin Liver Dis 18: 281-292
17. Kobayashi A, Itabashi F, Ohbe Y (1984) Long-term prognosis in biliary atresia after hepatic portoenterostomy: analysis of 35 patients who survived beyond 5 years of age. J Pediatr 105: 243-246
18. Ryckman F, Fisher R, Pederson S, et al (1993) Improved survival in biliary atresia patients in the present era of liver transplantation. J Pediatr Surg 28: 382-386
19. Paquet KJ (1982) Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices: a prospective controlled randomized trial. Endoscopy 14: 4-5
20. Altman RP, Chandra R, Lilly JR (1975) Ongoing cirrhosis after successful porticoenterostomy in infants with biliary atresia. J Pediatr Surg 10: 685-691
21. Ohi R, Nio M, Chiba T, Endo N, Goto M, Ibrahim M (1990) Long-term follow-up after surgery for patients with biliary atresia. J Pediatr Surg 25: 442-445
22. Laurent J, Ganthier F, Bernard O, et al (1990) Long-term outcome after surgery for biliary atresia: study of 40 patients surviving for more than 10 years. Gastroenterology 99: 1793-1797
23. Lilly JR, Karrer FM (1985) Contemporary surgery for biliary atresia. Pediatr Clin North Am 32: 1233-1246
24. Toyosaka A, Okamoto E, Okasora T, Nose K, Tomimoto Y (1993) Outcome of 21 patients with biliary atresia living more than 10 years. J Pediatr Surg 28: 1498-1501
25. Nio M, Ohi R, Hayashi Y, Endo N, Ibrahim M, Iwami D (1996) Current status of 21 living patients surviving more than 20 years after surgery for biliary atresia. J Pediatr Surg 31: 381-384
26. Lilly JR, Stellin G (1984) Variceal hemorrhage in biliary atresia. J Pediatr Surg 19: 476-479
27. Ristell J, Nieml S, Trivedi P, Maentausta O, Mowat AP, Ristell L (1988) Rapid equilibrium radioimmunoassay for the aminoterminal propeptide of human type III procollagen. Clin Chem 34: 715-718
28. Nakano H, Nakabayashi H, Okamoto Y, Kawayashi T, Seko S, Fukuda Y (1985) Serum levels of aminoterminal type III procollagen peptide in normal subjects and HF. Gastroenterol Jpn 20: 573-576
29. Trivedi P, Chesseman P, Portmann B, Hegarty J, Mowat AP (1985) Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur J Clin Invest 15: 69-74
30. Murawaki Y, Ikuta Y, Koda M, et al (1994) Serum type III procollagen peptide, type IV collagen 7S domain, central triple-helix of type IV collagen and tissue inhibitor of metalloproteinases in patients with chronic viral liver disease: relationship to liver histology. Hepatology 20: 780-787
31. Hayasaka A, Schuppan D, Ohnishi K, et al (1990) Serum concentrations of the carboxyterminal cross-linking domain of procollagen type IV (NCI) and the aminoterminal propeptide of procollagen type III (PIIIP) in chronic liver disease. J Hepatol 10: 17-22
32. Collazos J, Diaz F (1994) Role of the measurement of serum procollagen type III N terminal peptide in the evaluation of liver disease. Clin Chem Acta 227: 37-43